NO992731L - New Substituted Tetrahydropyridine Compounds, Methods of Preparing Them, and Pharmaceutical Compounds - Google Patents

New Substituted Tetrahydropyridine Compounds, Methods of Preparing Them, and Pharmaceutical Compounds

Info

Publication number
NO992731L
NO992731L NO992731A NO992731A NO992731L NO 992731 L NO992731 L NO 992731L NO 992731 A NO992731 A NO 992731A NO 992731 A NO992731 A NO 992731A NO 992731 L NO992731 L NO 992731L
Authority
NO
Norway
Prior art keywords
compounds
preparing
methods
new substituted
substituted tetrahydropyridine
Prior art date
Application number
NO992731A
Other languages
Norwegian (no)
Other versions
NO992731D0 (en
NO313589B1 (en
Inventor
Christian Marazano
Delphine Compere
C Bhupesh Das
Jean Lepagnol
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO992731D0 publication Critical patent/NO992731D0/en
Publication of NO992731L publication Critical patent/NO992731L/en
Publication of NO313589B1 publication Critical patent/NO313589B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention relates to compounds of general formula (I):in which R, R1, R2, X and Y are as defined in the description, their geometrical and/or optical isomers, and their addition salts with a pharmaceutically-acceptable acid or base, as well as to medicaments containing the same.
NO19992731A 1996-12-05 1999-06-04 New Substituted Tetrahydropyridine Compounds, Methods of Preparing Them and Pharmaceutical Compositions thereof NO313589B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614951A FR2756826B1 (en) 1996-12-05 1996-12-05 NOVEL SUBSTITUTED TETRAHYDROPYRIDINIC DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PCT/FR1997/002172 WO1998024765A1 (en) 1996-12-05 1997-12-02 Novel substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
NO992731D0 NO992731D0 (en) 1999-06-04
NO992731L true NO992731L (en) 1999-06-04
NO313589B1 NO313589B1 (en) 2002-10-28

Family

ID=9498371

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992731A NO313589B1 (en) 1996-12-05 1999-06-04 New Substituted Tetrahydropyridine Compounds, Methods of Preparing Them and Pharmaceutical Compositions thereof

Country Status (19)

Country Link
US (1) US6232319B1 (en)
EP (1) EP0937043B1 (en)
JP (1) JP3872821B2 (en)
CN (1) CN1126739C (en)
AT (1) ATE214051T1 (en)
AU (1) AU719208B2 (en)
CA (1) CA2274133C (en)
DE (1) DE69710909T2 (en)
DK (1) DK0937043T3 (en)
ES (1) ES2172023T3 (en)
FR (1) FR2756826B1 (en)
HK (1) HK1023346A1 (en)
HU (1) HUP0001773A3 (en)
NO (1) NO313589B1 (en)
NZ (1) NZ336111A (en)
PL (1) PL189372B1 (en)
PT (1) PT937043E (en)
WO (1) WO1998024765A1 (en)
ZA (1) ZA9710960B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2793245B1 (en) * 1999-05-05 2002-10-11 Adir NOVEL SUBSTITUTED PYRIDINIC OR PIPERIDINIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE10164139A1 (en) 2001-12-27 2003-07-10 Bayer Ag 2-heteroaryl carboxamides
US7238715B2 (en) * 2002-12-06 2007-07-03 The Feinstein Institute For Medical Research Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
ES2293086T3 (en) * 2002-12-06 2008-03-16 The Feinstein Institute For Medical Research INFLAMMATION INHIBITION USING COLINERGIC AGONISTS FROM UNION TO ALFA RECEIVER 7.
US8316104B2 (en) 2005-11-15 2012-11-20 California Institute Of Technology Method and apparatus for collaborative system
EP3357495B1 (en) 2008-11-19 2019-12-25 Axovant Sciences GmbH Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
MX2011011972A (en) * 2009-05-11 2011-12-08 Envivo Pharmaceuticals Inc Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors.
JP5749797B2 (en) 2010-05-17 2015-07-15 フォルム ファーマシューティカルズ、インコーポレイテッド Crystalline form of (R) -7-chloro-N- (quinuclidin-3-yl) benzo [B] thiophene-2-carboxamide hydrochloride monohydrate
WO2013169646A1 (en) 2012-05-08 2013-11-14 Envivo Pharmaceuticals, Inc. Methods of maintaining, treating or improving cognitive function

Also Published As

Publication number Publication date
PL189372B1 (en) 2005-07-29
PT937043E (en) 2002-07-31
FR2756826A1 (en) 1998-06-12
FR2756826B1 (en) 1999-01-08
JP2001505214A (en) 2001-04-17
HK1023346A1 (en) 2000-09-08
ATE214051T1 (en) 2002-03-15
NO992731D0 (en) 1999-06-04
CA2274133A1 (en) 1998-06-11
ES2172023T3 (en) 2002-09-16
AU719208B2 (en) 2000-05-04
CA2274133C (en) 2003-09-16
EP0937043A1 (en) 1999-08-25
ZA9710960B (en) 1998-06-15
DE69710909D1 (en) 2002-04-11
WO1998024765A1 (en) 1998-06-11
NO313589B1 (en) 2002-10-28
JP3872821B2 (en) 2007-01-24
CN1126739C (en) 2003-11-05
DK0937043T3 (en) 2002-06-10
DE69710909T2 (en) 2002-11-07
HUP0001773A2 (en) 2000-11-28
HUP0001773A3 (en) 2002-12-28
CN1239951A (en) 1999-12-29
EP0937043B1 (en) 2002-03-06
US6232319B1 (en) 2001-05-15
NZ336111A (en) 2000-03-27
AU7624398A (en) 1998-06-29

Similar Documents

Publication Publication Date Title
DK0562956T3 (en) New Naphthylalkylamines, Methods of Preparation and Pharmaceutical Agents Containing Them
KR900700486A (en) New benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of preparation and use
SE9904652D0 (en) Novel Compounds
NO20040680D0 (en) New dihydropterinone processes for their preparation and their use as a drug
DK0871606T3 (en) New compounds and their preparation with anti-inflammatory and anti-thrombotic activity
NO305596B1 (en) 1- (2-oxo-acetyl) -piperidine-2-carboxylic acid derivatives as multi-drug resistant sensitizers for cancer cells
DK0530087T3 (en) New Naphthylethylurea and Naphthylethylthiourea Compounds, Methods of Preparation and Pharmaceutical Agents Containing Them
DK0934309T3 (en) Novel pyridylalkanoic acid amides as cytostatic and immunosuppressive agents
ATE156829T1 (en) SUBSTITUTED AMINOPHOSPHONATE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NO992731D0 (en) New Substituted Tetrahydropyridine Compounds, Methods of Preparing Them, and Pharmaceutical Compounds
DK0632026T3 (en) Alpha-amino acid derivatives, a process for their preparation, and pharmaceutical compositions containing them
NO20023001L (en) Substituted piperazine derivatives as MTP inhibitors
CO4340625A1 (en) CONDENSED DIHYDROPYRIDINES AND THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS
ES2183492T3 (en) NEW NITRON DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DK0861250T3 (en) Amindine and isothiourea derivatives as inhibitors of nitrogen monoxide synthase
NO904135L (en) PROCEDURE FOR THE PREPARATION OF NEW SUBSTITUTED ALKYL PIPERIDINES AND THEIR USE AS INHIBITORS OF CHOLESTEROL SYNTHESIS.
DK1000067T3 (en) Thiazolobenzoheterocyclic compounds, their preparation and drugs containing the compounds
NO20000199D0 (en) Medications containing polyhydroxybutylpyrazines, new polyhydroxybutylpyrazines and their preparation
ATE50248T1 (en) AN IMIDAZOLIDINETRIONE DERIVATIVE OR A PHARMACEUTICAL COMPOSITION CONTAINING ITS PHARMACEUTICALLY ACCEPTABLE SALTS.
FR2640969B1 (en)
ES2065855B1 (en) PROCEDURE FOR THE PREPARATION OF NEW DEOXIAZAPHOSPHOLIPIDIC DERIVATIVES WITH INHIBITING ACTION OF THE PHOSFOLIPASE A2, NEW DERIVATIVES DEOXIAZAPHOSPHOLIPIDICES OBTAINED AND USE OF THEM.
ATE293635T1 (en) STREPTOGRAMINE DERIVATIVES, THEIR PRODUCTION AND PREPARATIONS CONTAINING THEM
NO20001541L (en) Novel substituted dimeric compounds, process for their preparation and pharmaceutical compositions containing them
DK0611755T3 (en) New (cyclohexyl) alkene compounds, processes for their preparation and pharmaceutical agents containing them
SE9803280D0 (en) Novel compounds